"Photosensitizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.
Descriptor ID |
D017319
|
MeSH Number(s) |
D27.505.954.444.600 D27.505.954.600.710
|
Concept/Terms |
Photosensitizing Effect- Photosensitizing Effect
- Effect, Photosensitizing
- Photosensitizing Effects
- Effects, Photosensitizing
|
Below are MeSH descriptors whose meaning is more general than "Photosensitizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Photosensitizing Agents".
This graph shows the total number of publications written about "Photosensitizing Agents" by people in this website by year, and whether "Photosensitizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2002 | 2 | 1 | 3 |
2003 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 2 | 0 | 2 |
2006 | 0 | 2 | 2 |
2007 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2013 | 2 | 1 | 3 |
2014 | 2 | 1 | 3 |
2015 | 2 | 0 | 2 |
2016 | 2 | 1 | 3 |
2017 | 4 | 1 | 5 |
2018 | 3 | 1 | 4 |
2019 | 2 | 2 | 4 |
2020 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
2022 | 1 | 2 | 3 |
2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Photosensitizing Agents" by people in Profiles.
-
Caccavale S, Boccellino MP, Brancaccio G, Alfano R, Argenziano G. Keratolytics can replace curettage in daylight photodynamic therapy for actinic keratosis on the face/scalp: A randomized clinical trial. J Eur Acad Dermatol Venereol. 2024 Mar; 38(3):594-601.
-
Hashemi H, Asgari S, Mahmoud AM, Mehravaran S, Roberts CJ. Variability of CLMI-X parameters, zonal Kmax, and single-point Kmax in keratoconus progression. Eye (Lond). 2023 10; 37(15):3197-3202.
-
Castillo O, Mancillas J, Hughes W, Brancaleon L. Characterization of the interaction of metal-protoporphyrins photosensitizers with ?- lactoglobulin. Biophys Chem. 2023 01; 292:106918.
-
Hashemi H, Roberts CJ, Ambr?sio R, Mehravaran S, Hafezi F, Vinciguerra R, Vinciguerra P, Panahi P, Asgari S. Comparative Contralateral Randomized Clinical Trial of Standard (3 mW/cm2) Versus Accelerated (9 mW/cm2) CXL in Patients With Down Syndrome: 3-Year Results. J Refract Surg. 2022 Jun; 38(6):381-388.
-
Yao YL, Wang YF, Li CX, Wu L, Tang GY. Management of oral leukoplakia by ablative fractional laser-assisted photodynamic therapy: A 3-year retrospective study of 48 patients. Lasers Surg Med. 2022 07; 54(5):682-687.
-
Yao Y, Shi L, Wang Y, Shen X, Ye S, Tang G, Wu L. Ablative fractional laser-assisted photodynamic therapy vs. ablative fractional laser for oral leukoplakia treatment: A randomized, controlled pilot study. Photodiagnosis Photodyn Ther. 2021 Dec; 36:102523.
-
Davis SA, Bovelle R, Han G, Kwagyan J. Corneal collagen cross-linking for bacterial infectious keratitis. Cochrane Database Syst Rev. 2020 06 17; 6:CD013001.
-
Singh S, Aggarwal A, Bhupathiraju NVSDK, Jovanovic IR, Landress M, Tuz MP, Gao R, Drain CM. Comparing a thioglycosylated chlorin and phthalocyanine as potential theranostic agents. Bioorg Med Chem. 2020 02 01; 28(3):115259.
-
Yao Y, Shen X, Shi L, Tang G, Wu L. The combination of photodynamic therapy and fractional CO2 laser for oral leukoplakia: Case series. Photodiagnosis Photodyn Ther. 2020 Mar; 29:101597.
-
Cozzolino M, Pesce L, Pezzuoli D, Montali C, Brancaleon L, Cavanna L, Abbruzzetti S, Diaspro A, Bianchini P, Viappiani C. Apomyoglobin is an efficient carrier for zinc phthalocyanine in photodynamic therapy of tumors. Biophys Chem. 2019 10; 253:106228.